Statute Details
- Title: Central Provident Fund (Designated Shares) Regulations 2022
- Act Code: CPFA1953-S290-2022
- Legislation Type: Subsidiary legislation (regulations made under the Central Provident Fund Act 1953)
- Enacting Authority: Minister for Manpower, after consulting the Central Provident Fund Board
- Authorising Provision: Section 77(1)(na) of the Central Provident Fund Act 1953
- Commencement: 1 April 2022
- Current Version Status: Current version as at 26 March 2026
- Key Subject Matter: Timing, procedure, and mechanics for vesting and sale (or transfer) of “designated shares” held in the Central Provident Fund (CPF) context, particularly upon a designated shareholder’s death
- Key Regulations (by heading): Regulations 1–12 and the Schedule
- Notable Amendment: Amended by S 280/2024 with effect from 1 April 2024 (as reflected in the extract)
What Is This Legislation About?
The Central Provident Fund (Designated Shares) Regulations 2022 (“Designated Shares Regulations”) set out the operational rules for how “designated shares” are handled by the Central Provident Fund Board (“the Board”) under section 26 of the Central Provident Fund Act 1953 (“the Act”). In practical terms, the Regulations focus on what happens to designated shares when a designated shareholder dies, including when the shares vest in the Board, how the Board sells them (if required), and how instructions from relevant persons must be received and acted upon.
Although the Act provides the broad legal framework, the Regulations supply the “nuts and bolts” that practitioners need: defined terms, prescribed time limits, the working-day mechanics for sale, and the procedural steps for giving and modifying instructions. The Regulations also address transitional and revocation issues, ensuring continuity when the legislative regime changes.
From a legal practice perspective, the Regulations are important because they govern time-sensitive decisions and actions. In estate-related CPF matters, delays or procedural missteps can affect whether designated shares are sold (and thus converted into cash) or transferred to a securities account. The Regulations therefore reduce uncertainty by prescribing when vesting occurs and when the Board must act.
What Are the Key Provisions?
1. Citation, commencement, and definitions (Regulations 1 and 2)
Regulation 1 provides the short title and commencement date: the Regulations come into operation on 1 April 2022. Regulation 2 defines key terms used throughout the instrument. These include “designated shareholder” and “designated shares” (by reference to the Act), “vested shares”, and “working day”. The Regulations also define “prescribed time” by reference to Regulation 5, and incorporate concepts such as “applicable person” and “relevant person” by cross-reference to the Act and related regulations.
Notably, Regulation 2(2) clarifies when the Board is “notified” of a designated shareholder’s death. The Board is notified if it has received satisfactory proof or reliable information from any person, and this applies regardless of whether the proof/information is received before, on, or after 1 April 2022. This matters because many downstream timelines (for vesting and sale/transfer) depend on the Board being notified.
2. Vesting of designated shares in the Board (Regulation 3)
Regulation 3 is central: it specifies the times and circumstances when designated shares vest in the Board under section 26(1) of the Act. Under Regulation 3(1), vesting occurs at the earliest of several triggers, including:
- Notification of death: when the Board is notified that the designated shareholder has died; and/or
- Board instructions to sell: on the date the Board (satisfied that a particular statutory condition applies) gives instructions to a stockbroker to sell on the next working day; and/or
- Dormancy trigger: when the designated shareholder’s CPF accounts are deemed dormant under section 2(1B) of the Act on or after 1 April 2022; and/or
- Authority for withdrawal (pre-1 April 2024): where the Board gives authority under section 15(1) of the Act (before 1 April 2024) for a specified withdrawal, and the designated shareholder has not instructed the Board to transfer designated shares to the designated shareholder’s securities account.
Regulation 3(2) then sets out the prescribed circumstances for vesting under section 26(1)(b) of the Act. In the extract, these include (a) dormancy of accounts on or after 1 April 2022, and (b) a transitional scenario involving Board authority for withdrawals under section 15(2)(b) or (c) as in force before 1 April 2024, where the designated shareholder has not instructed transfer to a securities account before the Board’s authority is given.
3. Sale where the Board receives instructions within prescribed time (Regulation 4)
Regulation 4 addresses the scenario where the Board receives instructions under section 26(4) of the Act within the prescribed time. It provides a structured rule: subject to exceptions and Regulation 11 (a modification provision), the Board must sell vested shares between the 8th and 10th working day (both inclusive) after the Board is satisfied that the instructions are duly made in the required manner.
Importantly, Regulation 4 also deals with subsequent instructions received after the prescribed time but before sale or transfer. The Board may transfer vested shares in accordance with later instructions (for example, switching from sale to transfer), or may sell in accordance with later instructions (switching from transfer to sale), depending on the timing and the statutory pathway invoked. This is a practical safeguard against rigid processing where estate representatives may need time to obtain documents or decide on the appropriate course.
4. Prescribed time for receipt of instructions (Regulation 5)
Regulation 5 is a key procedural rule. It prescribes the time within which the Board must receive instructions under section 26(4) for the purposes of section 26(6)(a) of the Act. The extract shows two main regimes:
- Death notified on or after 1 April 2022: instructions must be received 6 weeks after the date the Board receives the notification; and
- Death notified before 1 April 2022 but between 1 November 2015 and 31 March 2022: instructions must be received before 1 November 2022.
For practitioners, these cut-offs are critical. They determine whether the Board must treat instructions as “within prescribed time” and therefore apply the sale timing rules in Regulation 4 and related provisions.
5. Time of sale (Regulations 6 and 6A) and circumstances for sale (Regulation 7)
The extract indicates that Regulations 6 and 6A govern the time of sale of vested shares for purposes of section 26(6)(a) and section 26(6)(aa) of the Act, respectively. Regulation 6(1) (as shown) provides that, subject to exceptions, if the Board decides to sell because statutory circumstances exist, it must sell the shares within a specified working-day window after the Board is satisfied that instructions are duly made.
Regulation 7 then addresses circumstances and time for sale for purposes of section 26(6)(b) of the Act. While the extract is truncated mid-sentence, the structure of the Regulations makes clear that the instrument is designed to map statutory triggers to concrete sale timelines, including how the Board acts when instructions are not received by deadlines, or when statutory conditions require sale regardless of instructions.
6. Account, stockbroker appointment, and instruction mechanics (Regulations 8–10)
Regulation 8 prescribes the account under section 26(9) of the Act. Regulation 9 provides for appointing a stockbroker, which is operationally essential because sale of shares must be executed through a broker. Regulation 10 sets out the form and manner of instructions—another practical compliance point. For estate administrators and solicitors, the “manner” requirement can be decisive: instructions must be made in the way the Board requires, and the Board must be satisfied that they are duly made.
7. Modification of time to sell and transitional provisions (Regulations 11 and 12)
Regulation 11 provides for modification in time to sell vested shares. This likely addresses exceptional circumstances (for example, where sale timing must be adjusted due to operational constraints or statutory interpretation). Regulation 12 deals with revocation and transitional provisions, ensuring that changes introduced by the 2022 Regulations (and later amendments) do not create gaps or unfair outcomes for cases already in progress.
8. The Schedule
The Schedule prescribes circumstances under section 26(6)(b) and the time for sale of vested shares. Schedules in Singapore subsidiary legislation typically function as detailed mappings that practitioners should consult alongside the main regulations.
How Is This Legislation Structured?
The Regulations are structured as follows:
- Regulation 1: Citation and commencement.
- Regulation 2: Definitions and the “notification of death” rule.
- Regulation 3: Times and circumstances for vesting of designated shares in the Board under section 26(1) of the Act.
- Regulation 4: Sale of shares where the Board receives instructions under section 26(4) within prescribed time, including rules for subsequent instructions.
- Regulation 5: Prescribed time for receipt of instructions for section 26(6)(a).
- Regulations 6 and 6A: Time of sale for different statutory sub-clauses (section 26(6)(a) and section 26(6)(aa)).
- Regulation 7: Circumstances and time for sale for section 26(6)(b).
- Regulation 8: Prescribed account under section 26(9).
- Regulation 9: Appointing a stockbroker.
- Regulation 10: Form and manner of instructions.
- Regulation 11: Modification in time to sell.
- Regulation 12: Revocation and transitional provisions.
- The Schedule: Prescribed circumstances and time for sale under section 26(6)(b).
Who Does This Legislation Apply To?
The Regulations apply primarily to the Central Provident Fund Board and to persons who give instructions to the Board in relation to a deceased designated shareholder. The operative concepts—“designated shareholder”, “designated shares”, “vested shares”, “relevant person”, and “nominee”—are defined by reference to the Act and related CPF regulations.
In practice, the Regulations will be relevant to estate representatives (such as executors, administrators, or nominees) and their advisers, because these parties must ensure that instructions are submitted within the prescribed time limits and in the required form. The Board’s obligations to sell or transfer designated shares are triggered by notification of death, dormancy status, and the receipt (or non-receipt) of instructions within the timeframes set out in the Regulations.
Why Is This Legislation Important?
This subsidiary legislation is important because it operationalises a sensitive intersection between CPF administration and estate processes. Designated shares are not simply “frozen” upon death; instead, they follow a legally defined pathway that can result in sale and conversion to cash, or transfer to a securities account, depending on statutory triggers and timely instructions.
For practitioners, the Regulations matter in at least three ways. First, they impose clear timing rules (for example, the 6-week prescribed period in Regulation 5 and the 8th–10th working day sale window in Regulation 4). Second, they define when vesting occurs (Regulation 3), which affects the legal status of the shares and the Board’s authority to act. Third, they require compliance with instruction formalities (Regulation 10) and provide mechanisms for handling subsequent instructions (Regulation 4), which can occur frequently in real estate/estate administration workflows.
Finally, the inclusion of transitional and amendment-aware provisions (as reflected by the 2024 amendment) underscores that practitioners must check the current version and the relevant dates of notification, dormancy, and Board authority. A correct timeline analysis can determine whether the Board must sell, whether it may transfer, and when the estate representative’s options are still available.
Related Legislation
- Central Provident Fund Act 1953 (especially section 26 and section 77(1)(na), and section 15 and section 2(1B) as referenced)
- Central Provident Fund (Prescribed Applicable Person) Regulations 2024 (as referenced for “applicable person”)
- Central Provident Fund (Designated Shares) Regulations 2022 amendments: S 280/2024 (with effect from 1 April 2024)
Source Documents
This article provides an overview of the Central Provident Fund (Designated Shares) Regulations 2022 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.